文献速递胸部肿瘤放疗放疗物理与技术

超中央型肺癌消融放疗的剂量学、几何学与体积学预测因素

Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity.
PubMed 文献 · Radiother Oncol · 2021-03-10

常见方案为50 Gy/5次(57%)、60 Gy/8次(15%)、48 Gy/4次(13%)。1、2、5年总生存率分别为78%、57%、32%,局部进展率分别为4%、16%、21%,4%患者出现致死性毒性。

要点

  • GTV最低剂量较低和GTV/PTV体积比偏高与局部进展相关。
  • GTV或PTV接触近端支气管树、距离食管或PBT更短与死亡风险相关。
  • 心包最大剂量、肺V20Gy和平均肺剂量是需要权衡的正常组织剂量参数。

核心结论

  • GTV最低剂量较低和PTV体积扩展较小可能增加局部进展风险,需与心包最大剂量、肺V20Gy和平均肺剂量等正常组织剂量平衡。

研究设计与样本

  • 使用自定义软件计算靶区和危及器官体积,并测量体积间最短向量长度。

主要发现

  • 常见剂量分割方案为50 Gy/5次(57%)、60 Gy/8次(15%)、48 Gy/4次(13%)。
  • 1、2、5年总生存率分别为78%、57%、32%。
  • 1、2、5年局部进展率分别为4%、16%、21%。
  • 急性与晚期2级及以上毒性发生率分别为18%和27%,4例(4%)出现致死性毒性。
  • 与死亡显著相关的因素包括:腔内肿瘤、GTV或PTV接触PBT、GTV到PBT或食管距离较短、PBT接受处方剂量的体积、较高的心包最大剂量、肺V20Gy和平均肺剂量。

临床怎么用

  • 制定超中央型肺癌消融放疗计划时,应关注GTV最低剂量和PTV体积扩展,同时限制心包最大剂量、肺V20Gy和平均肺剂量。
  • 对GTV或PTV接触PBT、距离食管或PBT较近的患者,需加强剂量学评估与毒性监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ultracentral lung cancers arise near the proximal bronchial tree (PBT), trachea, or esophagus, and have been associated with worse outcomes and increased toxicity after radiotherapy. We sought to associate dosimetric and anatomic factors with oncologic outcomes and toxicities. METHODS: One-hundred ten patients treated with ablative, curative-intent radiotherapy for ultracentral, node-negative, non-small cell lung cancer were included. Dosimetric and geometric data obtained using custom software that calculated volumes of target structures and organs-at-risk and measured the shortest vector length between these volumes were associated with outcomes and toxicity. RESULTS: Common dose/fractionation schemes included 50 Gy in 5 fractions (57%), 60 Gy in 8 fractions (15%), and 48 Gy in 4 fractions (13%). Overall survival at 1, 2, and 5 years was 78%, 57%, and 32%, respectively. Factors significantly associated with death included endobronchial tumor, gross tumor volume (GTV) or planning target volume (PTV) contacting PBT, shorter distance from GTV to PBT or esophagus, volume of PBT receiving prescription dose, higher pericardium max dose, lung V20Gy, and mean lung dose. Local progression at 1, 2, and 5 years was 4%, 16%, and 21%. Factors associated with local progression were lower GTV minimum dose and higher GTV/PTV volume ratio. Acute and late grade 2 + toxicity was seen in 18% and 27%, respectively. Four patients (4%) had fatal toxicity. CONCLUSIONS: Lower GTV minimum dose and smaller volumetric PTV expansions may increase risk of local progression, and should be balanced against normal tissue doses including pericardium maximum dose, lung V20Gy, and mean lung dose.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Breen WG, Jeans EB, Gergelis KR, et al. Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity. Radiother Oncol. 2021. PMID: 33711411. doi:10.1016/j.radonc.2021.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。